Therefore, unlike unexposed patients, increased tumor-infiltrating CD8<sup>+</sup> T-cells in anti-cancer therapy-exposed tumoral tissues can be associated with the inferior prognosis of affected patients. This evidence concerns the gene CD8A and cancer.